{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:41:25Z","timestamp":1763142085376,"version":"3.41.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> There is no validated tool to assess patients\u2019 knowledge of oral anticoagulant therapy in atrial fibrillation in China.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Using a standard translation program, the Jessa Atrial fibrillation Knowledge Questionnaire (JAKQ) was translated into Chinese. The reliability of the JAKQ was assessed by internal consistency (Cronbach\u2019s \u03b1 coefficient), repeatability (test-retest reliability), and sensitivity tests. Effectiveness was assessed by hypothesizing that a lower JAKQ score was a risk factor for bleeding. A total of 447 patients with atrial fibrillation (AF) who were hospitalized between July 2019 and December 2021 were studied and followed up. Participants were followed up 1, 3, 6, and 12 months after enrollment. Bleeding during follow-up was recorded. Data were obtained from hospital databases and telephone follow-up.<\/jats:p><jats:p><jats:bold>Result:<\/jats:bold> A total of 447 patients with AF completed JAKQ. The mean age of patients was 67.7 \u00b1 10.2\u00a0years. The median JAKQ score was 31.3% (12.5\u201343.8). The Cronbach\u2019s \u03b1 coefficient of JAKQ was 0.616\u20130.637, and the test-retest reliability value was 0.902 (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). Multivariate logistic regression showed that the higher knowledge level of AF was associated with secondary education or above, an income of more than 2000 yuan, and a history of AF of more than 1\u00a0year. Bleeding was associated with a lower JAKQ score, hypertension, and a history of bleeding. Non-bleeding patients on VKA had a better understanding of how often INR should be monitored and what to do if an OAC dose was missed.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The Chinese version of JAKQ shows good reliability and validity, indicating that it is a valuable tool for AF and oral anticoagulation (OAC) knowledge assessment. It can be used in clinical practice to guide educational activities and improve the effectiveness and safety of treatment. It was shown that Chinese patients with AF have insufficient knowledge about AF and OAC. Lower JAKQ scores are associated with bleeding, so targeted education is necessary. Targeted educational efforts should focus on patients recently diagnosed with AF and those with lower formal education and income.<\/jats:p>","DOI":"10.3389\/fphar.2023.1148524","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T04:20:34Z","timestamp":1686630034000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire"],"prefix":"10.3389","volume":"14","author":[{"given":"Sijie","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lien","family":"Desteghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ijcard.2019.07.026","article-title":"Mobile health applications for atrial fibrillation: A readability and quality assessment","volume":"293","author":"Ayyaswami","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e74037","DOI":"10.1371\/journal.pone.0074037","article-title":"Educational intervention improves anticoagulation control in atrial fibrillation patients: The TREAT randomised trial","volume":"8","author":"Clarkesmith","year":"2013","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.ijcard.2016.08.303","article-title":"Knowledge gaps in patients with atrial fibrillation revealed by a new validated knowledge questionnaire","volume":"223","author":"Desteghe","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1177\/1474515118804353","article-title":"Effect of reinforced, targeted in-person education using the Jessa atrial fibrillation knowledge questionnaire in patients with atrial fibrillation: A randomized controlled trial","volume":"18","author":"Desteghe","year":"2019","journal-title":"Eur. J. Cardiovasc Nurs."},{"key":"B5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/bmj.325.7362.472","article-title":"Consultation length in general practice: Cross sectional study in six European countries","volume":"325","author":"Deveugele","year":"2002","journal-title":"Bmj"},{"key":"B6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ienj.2017.03.006","article-title":"Long-term benefits of education by emergency care nurses at discharge of patients with atrial fibrillation","volume":"35","author":"Fuenzalida","year":"2017","journal-title":"Int. Emerg. Nurs."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa2029603","article-title":"Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve","volume":"383","author":"Guimar\u00e3es","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.amjmed.2017.07.003","article-title":"Mobile health technology for atrial fibrillation management integrating decision support, education, and patient involvement: mAF app trial","volume":"130","author":"Guo","year":"2017","journal-title":"Am. J. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann. Intern Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1093\/eurheartj\/ehw058","article-title":"Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary","volume":"38","author":"Heidbuchel","year":"2017","journal-title":"Eur. Heart J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/ajh\/hpx094","article-title":"Relationship of hypertension and systolic blood pressure with the risk of stroke or bleeding in patients with atrial fibrillation: The fushimi AF registry","volume":"30","author":"Ishii","year":"2017","journal-title":"Am. J. Hypertens."},{"key":"B13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5603\/KP.a2019.0036","article-title":"Polish regional differences in patient knowledge on atrial fibrillation and its management as well as in patterns of oral anticoagulant prescription","volume":"77","author":"Janion-Sadowska","year":"2019","journal-title":"Kardiol. Pol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0135121","DOI":"10.1371\/journal.pone.0135121","article-title":"The length and content of general practice consultation in two urban districts of beijing: A preliminary observation study","volume":"10","author":"Jin","year":"2015","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.thromres.2022.03.011","article-title":"Knowledge about atrial fibrillation and anticoagulation affects the risk of clinical outcomes","volume":"213","author":"Konieczy\u0144ska","year":"2022","journal-title":"Thromb. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.5603\/KP.a2018.0069","article-title":"Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists","volume":"76","author":"Konieczy\u0144ska","year":"2018","journal-title":"Kardiol. Pol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/europace\/eux299","article-title":"European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers","volume":"20","author":"Kotecha","year":"2018","journal-title":"Europace"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-200485","article-title":"Design considerations for mobile health applications targeting older adults","volume":"79","author":"Li","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1001\/jama.2015.4369","article-title":"Stroke prevention in atrial fibrillation: A systematic review","volume":"313","author":"Lip","year":"2015","journal-title":"Jama"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1001\/archinte.163.13.1580","article-title":"Anticoagulant-related bleeding in older persons with atrial fibrillation: Physicians' fears often unfounded","volume":"163","author":"Man-Son-Hing","year":"2003","journal-title":"Arch. Intern Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e008643","DOI":"10.1161\/JAHA.118.008643","article-title":"Effectiveness and safety of apixaban, dabigatran, and rivaroxaban versus warfarin in frail patients with nonvalvular atrial fibrillation","volume":"7","author":"Martinez","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1080\/14656566.2020.1799976","article-title":"Antithrombotic therapy for stroke prevention in patients with atrial fibrillation in Japan","volume":"21","author":"Maruhashi","year":"2020","journal-title":"Expert Opin. Pharmacother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e13483","DOI":"10.1111\/ijcp.13483","article-title":"Minor bleeding affects the level of knowledge in patients with atrial fibrillation on oral anticoagulant therapy","volume":"74","author":"Metzgier-Gumiela","year":"2020","journal-title":"Int. J. Clin. Pract."},{"key":"B25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1055\/s-0041-1726332","article-title":"Atrial fibrillation and ischemic stroke: A clinical review","volume":"41","author":"Migdady","year":"2021","journal-title":"Semin. Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0158071","DOI":"10.1371\/journal.pone.0158071","article-title":"Development and validation of an oral anticoagulation knowledge tool (AKT)","volume":"11","author":"Obamiro","year":"2016","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5152\/eurasianjmed.2021.20247","article-title":"Turkish validity and reliability study of Jessa atrial fibrillation knowledge questionnaire (JAKQ)","volume":"53","author":"\u00d6zl\u00fc","year":"2021","journal-title":"Eurasian J. Med."},{"volume-title":"Global data set on education quality (1965-2015)","year":"2018","author":"Patrinos","key":"B28"},{"key":"B29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.31083\/j.rcm2203076","article-title":"Management of antithrombotic therapy in patients with atrial fibrillation and acute coronary syndromes","volume":"22","author":"Pop","year":"2021","journal-title":"Rev. Cardiovasc Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"684638","DOI":"10.3389\/fphar.2021.684638","article-title":"Direct oral anticoagulants: From randomized clinical trials to real-world clinical practice","volume":"12","author":"Roberti","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/heartjnl-2020-318753","article-title":"Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation","volume":"108","author":"Rutherford","year":"2022","journal-title":"Heart"},{"key":"B32","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00228-020-02856-6","article-title":"Risk factors for severe bleeding events during warfarin treatment: The influence of sex, age, comorbidity and co-medication","volume":"76","author":"Rydberg","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"B34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pec.2020.07.008","article-title":"Sociodemographic, behavioral, and clinical factors associated with low atrial fibrillation knowledge among older adults with atrial fibrillation: The SAGE-AF study","volume":"104","author":"Sedney","year":"2021","journal-title":"Patient Educ. Couns."},{"key":"B35","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/clc.23361","article-title":"Knowledge, attitude, and practice regarding atrial fibrillation among neurologists in central China: A cross-sectional study","volume":"43","author":"Shen","year":"2020","journal-title":"Clin. Cardiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2261-10-21","article-title":"TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)","volume":"10","author":"Smith","year":"2010","journal-title":"BMC Cardiovasc Disord."},{"key":"B37","doi-asserted-by":"publisher","first-page":"100201","DOI":"10.1016\/j.ajpc.2021.100201","article-title":"Association of income and educational attainment in hospitalization events in atrial fibrillation","volume":"7","author":"Tertulien","year":"2021","journal-title":"Am. J. Prev. Cardiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.33963\/KP.15205","article-title":"Bleeding in anticoagulated patients with atrial fibrillation: Practical considerations","volume":"130","author":"Undas","year":"2020","journal-title":"Pol. Arch. Intern Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/CIRCRESAHA.117.311402","article-title":"Hypertension and atrial fibrillation: Doubts and certainties from basic and clinical studies","volume":"122","author":"Verdecchia","year":"2018","journal-title":"Circ. Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/S0140-6736(17)32165-7","article-title":"A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): An international, cluster-randomised trial","volume":"390","author":"Vinereanu","year":"2017","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"108029","DOI":"10.1016\/j.jdiacomp.2021.108029","article-title":"Effectiveness and safety of rivaroxaban versus warfarin among nonvalvular atrial fibrillation patients with obesity and diabetes","volume":"35","author":"Weir","year":"2021","journal-title":"J. Diabetes Complicat."},{"key":"B42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","article-title":"Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) Measures: Report of the ISPOR task force for translation and cultural adaptation","volume":"8","author":"Wild","year":"2005","journal-title":"Value Health"},{"volume-title":"World Health Organization [webpage on the Internet]. Process of translation and adaptation of instruments","year":"2017","key":"B43"},{"key":"B44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10840-010-9496-2","article-title":"Knowledge, attitude, and behavior in patients with atrial fibrillation undergoing radiofrequency catheter ablation","volume":"28","author":"Xu","year":"2010","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12875-020-01236-4","article-title":"A study of knowledge, attitudes, and practices of primary care physicians toward anticoagulant therapy in patients with non-valvular atrial fibrillation in Shanghai, China","volume":"21","author":"Ye","year":"2020","journal-title":"BMC Fam. Pract."},{"key":"B46","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1345\/aph.1G562","article-title":"Development and validation of an instrument to determine patient knowledge: The oral anticoagulation knowledge test","volume":"40","author":"Zeolla","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2188\/jea.je2008021","article-title":"An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China","volume":"18","author":"Zhou","year":"2008","journal-title":"J. Epidemiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1148524\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T09:57:55Z","timestamp":1687341475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1148524\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":47,"alternative-id":["10.3389\/fphar.2023.1148524"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1148524","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"article-number":"1148524"}}